Home › Prescription medicine › BioSpectra, Inc. — Biospectra…
BioSpectra, Inc. — Biospectra Tris/Tromethamine, USP, GMP, API Grade
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Failed stability specifications
The Recall Registry rates this serious — FDA Class II: temporary or medically reversible health harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: BioSpectra, Inc.
The product
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
Details
- Units affected
- 200 kg
- Recall date
- July 29, 2026
- Brand
- BioSpectra, Inc.
CA
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “BioSpectra, Inc. — Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine